The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 262.00
Bid: 262.60
Ask: 263.00
Change: 0.20 (0.08%)
Spread: 0.40 (0.152%)
Open: 262.20
High: 264.00
Low: 261.20
Prev. Close: 261.80
CTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convatec Group PLC: Result of AGM

18 May 2023 16:15

Convatec Group PLC (CTEC) Convatec Group PLC: Result of AGM 18-May-2023 / 16:15 GMT/BST


Convatec Group Plc

 

Results of Annual General Meeting

 

Reading, United Kingdom (18 May 2023) – Poll Result

Convatec Group Plc ("Convatec") held its Annual General Meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below. All resolutions were passed.

 

 

For (see note 2)

Against (see note 2)

Votes Total

(excluding withheld)

% of ISC Voted

Votes Witheld

Resolution

No of shares

%

No of Shares

%

1

To receive Annual Report and Accounts 2022

1,811,087,597

100.00%

1,246

0.00%

1,811,088,843

88.61%

1,443,683

2

To approve the Directors’ Remuneration report

1,776,692,442

98.03%

35,748,711

1.97%

1,812,441,153

88.68%

91,373

3

To Approve the Remuneration Policy

1,730,855,151

95.95%

72,994,765

4.05%

1,803,849,916

88.26%

8,682,610

4

To declare a final dividend

1,800,183,202

99.32%

12,307,251

0.68%

1,812,490,453

88.68%

42,073

5

To re-elect Dr John McAdam as a Director

1,772,203,651

97.78%

40,257,733

2.22%

1,812,461,384

88.68%

71,142

6

To re-elect Karim Bitar as a Director

1,808,728,508

99.79%

3,735,216

0.21%

1,812,463,724

88.68%

68,802

7

To re-elect Jonny Mason as a Director

1,804,110,747

99.54%

8,343,677

0.46%

1,812,454,424

88.68%

78,102

8

To re-elect Margaret Ewing as a Director

1,732,196,028

95.57%

80,265,356

4.43%

1,812,461,384

88.68%

71,142

9

To re-elect Brian May as a Director

1,729,029,346

95.41%

83,268,401

4.59%

1,812,297,747

88.67%

234,779

10

To re-elect Professor Constantin Coussios as a Director

1,777,552,488

98.08%

34,752,027

1.92%

1,812,304,515

88.67%

228,011

11

To re-elect Heather Mason as a Director

1,788,735,494

98.69%

23,710,523

1.31%

1,812,446,017

88.68%

86,509

12

To re-elect Kim Lody as a Director

1,777,328,039

98.07%

34,965,409

1.93%

1,812,293,448

88.67%

239,078

13

To re-elect Sharon O’Keefe as a Director

1,777,538,827

98.08%

34,754,621

1.92%

1,812,293,448

88.67%

239,078

14

To re-elect Sten Scheibye as a Director

1,808,751,065

99.80%

3,694,952

0.20%

1,812,446,017

88.68%

86,509

15

To re-appoint Deloitte LLP as auditor

1,810,914,607

100.00%

35,710

0.00%

1,810,950,317

88.60%

1,582,209

16

To authorise the Directors to agree the remuneration of the auditor

1,812,433,628

100.00%

13,193

0.00%

1,812,446,821

88.68%

85,705

17

To authorise political donations and political expenditure

1,805,711,975

99.65%

6,379,062

0.35%

1,812,091,037

88.66%

441,489

18

To authorise allotment of shares

1,652,944,663

91.20%

159,555,414

8.80%

1,812,500,077

88.68%

32,449

19

To disapply pre-emption rights*

1,753,138,056

96.74%

59,096,058

3.26%

1,812,234,114

88.67%

298,412

20

 

To disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,718,475,435

 

 

 

 

 

 

95.61%

 

 

 

 

 

78,988,318

 

 

 

 

 

 

4.39%

 

 

 

 

 

1,797,463,753

 

 

 

 

 

 

87.94%

 

 

 

 

 

15,068,773

21

To authorise purchase of own shares*

1,810,135,610

99.91%

1,546,844

0.09%

1,811,682,454

88.64%

850,072

22

To call general meetings on not less than 14 days’ notice*

1,769,469,226

97.63%

42,955,036

2.37%

1,812,424,262

88.68%

108,264

*Special Resolution

NOTES:

All resolutions were passed. Votes “For” and “Against” are expressed as a percentage of votes received. A “Vote withheld” is not a vote in law and is not counted in the calculation of the votes “For” or “Against” a resolution. Total number of shares in issue is 2,043,872,048 (88.61% of capital was voted). Computershare acted as scrutineer of the poll on all resolutions.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Annual General Meeting have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Enquiries 

 

Louise Bryson, Assistant Company Secretary                                 +44(0)7423 694919 

Cosec@convatec.com  

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92  

 

About Convatec 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com. 

 

###

END


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:GB00BD3VFW73
Category Code:RAG
TIDM:CTEC
LEI Code:213800LS272L4FIDOH92
Sequence No.:244813
EQS News ID:1636649
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
13th Sep 202212:08 pmEQSConvatec Group PLC: Scrip Dividend – Calculation Price
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
4th Aug 20227:00 amRNSInterim Results
7th Jul 202211:53 amRNSDirector Declaration
28th Jun 20225:26 pmRNSBlock listing Interim Review
31st May 20222:00 pmRNSTotal Voting Rights
19th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20224:25 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update
4th May 20223:31 pmRNSScrip Dividend - Total Issued Shares
3rd May 20227:00 amRNSNotice of Forthcoming Scheduled IR Events
7th Apr 20223:45 pmRNSScrip Dividend – Calculation Price
1st Apr 20224:00 pmRNSHolding(s) in Company
31st Mar 20223:45 pmRNSTotal Voting Rights
30th Mar 202212:00 pmRNSAnnual Report and Accounts 2021 and Notice of AGM
25th Mar 20222:00 pmRNSDirector/PDMR Shareholding
23rd Mar 202211:30 amRNSDirector/PDMR Shareholding
17th Mar 20222:40 pmRNSDirector/PDMR Shareholding
17th Mar 20222:20 pmRNSBoard Change
14th Mar 20227:00 amRNSAcquisition Completion of Triad Life Sciences Inc
8th Mar 20227:00 amRNSAnnual Results
28th Feb 202211:00 amRNSNon-Executive Director Changes
10th Feb 20223:15 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSAcquisition: entry into attractive wound biologics
27th Jan 202211:00 amRNSBoard Committee Changes
20th Dec 20218:45 amRNSBlock Listing Application
16th Dec 20212:00 pmRNSNon-Executive Director appointment
9th Dec 20217:00 amRNSChief Financial Officer succession
1st Nov 20213:35 pmRNSTotal Voting Rights
29th Oct 20217:00 amRNSQ3 Trading Update
18th Oct 20214:30 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPricing of $500M 3.875% Senior Notes due 2029
30th Sep 20211:13 pmRNSConvaTec Announces Offer of $500M Senior Notes
28th Sep 20213:15 pmRNSScrip Dividend - Total Issued Shares
9th Sep 20213:00 pmRNSScrip Dividend - Calculation Price
30th Jul 20213:45 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSInterim Results
28th Jun 202112:40 pmRNSDirector Declaration
1st Jun 202111:45 amRNSTotal Voting Rights
17th May 20213:15 pmRNSDirector/PDMR Shareholding
7th May 20212:50 pmRNSResult of AGM
29th Apr 20217:00 amRNSQ1 Trading Update
28th Apr 202112:45 pmRNSScrip Dividend - Total Issued Shares
12th Apr 20213:15 pmRNSScrip Dividend - Calculation Price
22nd Mar 20213:40 pmRNSAnnual Report and Accounts 2020 and Notice of AGM
11th Mar 20213:50 pmRNSDirector/PDMR Shareholding
5th Mar 20217:00 amRNSAnnual Results
22nd Feb 202111:30 amRNSDirector Declaration
21st Dec 202011:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.